Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, A. M.
Right arrow Articles by Berman, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, A. M.
Right arrow Articles by Berman, A. R.
Related Content
Right arrow Chest Imaging and Pathology for Clinicians
(Chest. 2007;131:294-299.)
© 2007 American College of Chest Physicians

A Localized Pleural Based Mass With Intense Uptake on Positron Emission Tomography Scan*

Amir M. Khan, MD, MSc; Kaoutar Tlemcani, MD; Nataraj Shanmugam, MD; Dingming Y, MD; Steven Keller, MD and Andrew R. Berman, MD

* From the Departments of Pulmonary Medicine (Drs. Khan and Berman), Oncology (Dr. Tlemcani), Nuclear Medicine (Dr. Shanmugam), Pathology (Dr. Y), and Surgery (Dr. Keller), Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.

Correspondence to: Amir M. Khan, MD, MSc, 3600 Fieldston Rd, No. 7C, Bronx, NY 10463; e-mail: dramirkhan{at}hotmail.com

A 77-year-old man was referred for evaluation of a left chest mass found on a routine radiograph during hospitalization for a myocardial infraction. The patient underwent successful coronary stenting for occluded right coronary and left circumflex coronary vessels and remained asymptomatic.

His medical history was significant for hypertension, hyperlipidemia, benign prostatic hypertrophy, and peripheral vascular disease. He had undergone a carotid endarterectomy 2 years prior to this hospital admission. His medications included atenolol, aspirin, clopidogrel, pantoprazole, simvastatin, tamsulosin, and amlodipine. His social history was remarkable for cigarette smoking (1 pack a day for > 50 years) until he quit 4 years ago. He was retired from the merchant marine, and his work involved ship repair for several weeks at a time. No clear asbestos exposure could be established. His purified protein derivative status was negative. His vital signs, the findings of physical and cardiopulmonary examinations, and results of basic laboratory investigations were unremarkable on presentation.

Radiologic Findings

A plain chest radiograph showed a solitary opacification on the left side of the chest. A CT scan of the chest revealed a 2 x 1 cm soft homogenous lesion in the anterior left hemithorax forming oblique angles with adjacent lung parenchyma consistent with either pleural or extrapleural origin, without evidence of apparent chest wall or rib involvement. No adjacent bony destruction or invasion was noted. A corresponding intense focal fluorodeoxyglucose uptake was noted on positron emission tomography (PET) scans of the chest (Fig 1, 2 ).


Figure 1
View larger version (80K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1.. Top, A: chest radiograph (anteroposterior view), showing a solitary pulmonary left nodule. Bottom, B: CT scan of the chest-lung window showing the left anterior nodule, which is pleura-based.

 

Figure 2
View larger version (46K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2.. PET scan image showing the uptake of the anterior left nodule.

 
The patient underwent a left thoracoscopic resection of this parietal pleura-based mass. At the time of surgery, no other lesions were noted in the lung, pleura, or chest surface. The mass was removed en bloc and sent for pathologic examination.

Pathologic Findings

On gross inspection, a tan white homogenous 1.7 x 1.2 x 0.6 cm mass was noted. On cut section, small foci of yellow nodules (maximum dimension, 0.1 x 0.2 cm) were also noted.

Histology confirmed tumor cells of epithelioid proliferation, which formed diffuse sheets and showed focal infiltration into an associated dense fibrotic stroma but without infiltration of any of the margins of the specimen. The immunophenotype of the cells confirmed the diagnosis of mesothelioma as they stained strongly positive for CK 5/6, and calretinin (cytoplasmic staining with nuclear sparing), and were negative for other immunomarkers (eg, TTF1, WT1, BerEP4, B72.3, CD34, Bcl2, and CEA polyclonal) [Fig 3, 4 ].


Figure 3
View larger version (163K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3.. Histology at low power (hematoxylin-eosin, original x40). At lower power, the pleural surface is smooth and fibrotic. The lesion shows sheets of epithelioid cells with centrally located nuclear cytoplasm and an ample amount of eosinophilic cytoplasm. The immunostains are negative for TTF-1, but positive for CK5/6.

 

Figure 4
View larger version (142K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4.. Histology at high power (hematoxylin-eosin, original x40). High-power epithelioid cells.

 
The patient had made an uneventful recovery postoperatively. No recurrence was been detected at his 1-year follow-up visit.

What is the diagnosis?

Diagnosis: Localized malignant mesothelioma

Discussion

Mesothelioma is a primary tumor of the serosal membranes that can involve the pleura, peritoneum, and pericardium.1 Diffuse malignant mesothelioma (DMM) is an aggressive variant that grows widely over the serosal membrane surfaces; patients have very poor outcomes, with death occurring within 24 months of its diagnosis in most cases. DMM presents with its characteristic extensive studding of the serosal surface by tumor nodules, which progresses to the encasement of organs in the later stages.23 A small number of cases of so-called localized malignant mesothelioma (LMM) have been described in the literature with immunohistochemical and ultrastructural features that are identical to those of DMM, but with improved clinical outcomes (Table 1Go ).4567891011121314151617


View this table:
[in this window]
[in a new window]

 
Table 1.. Localized Mesotheliomas*

 

View this table:
[in this window]
[in a new window]

 
Table 1A.. continued

 
The term localized malignant mesothelioma of the pleura was described by Wagner as early as 1870.18 Distinction between the local and diffuse forms was provided in 1931 by Klemperer and Rabin.19 Up to 1950,20 and then from 1950 to 1978,21 only a handful of cases were reported. In 1994, Crotty et al12 described a series of six patients and redefined LMM based on modern immunohistochemical features. The 2004 World Health Organization classification of tumors of the pleura recognized LMM as a separate entity.22

Clinical and Radiologic Discussion
LMMs are rare, solitary, circumscribed, nodular tumors, which are attached to the surface of the pleura, peritoneum, or pericardium. Malignant mesotheliomas are predominately of three types (Table 1)Go. Most LMMs are incidental findings or present with nonspecific symptoms. Unlike the situation with DMMs, in which most cases occur in men, the sex ratio of patients with LMMs is approximately equal in our review (Table 1)Go.

While DMM is associated with asbestos exposure, in our review of 35 cases of LMM, only 5 cases had a definite history of exposure and another 3 cases had a history that was suspicious for exposure. Since information about asbestos exposure was not available in many of the cases, we were unable to ascertain the role of asbestos exposure nor were we able to establish any other common etiology in the causation of LMM (Table 1)Go.

Patients in reported cases of LMM have had tumor varying in size from as small as 1.8 cm to as large as 10 cm. The pattern shown by CT scans in this case, consisting of a small localized subpleural nodule, is much more likely to be a solitary fibrous tumor (SFT) than a malignant mesothelioma. The diagnosis of localized mesothelioma can only be distinguished pathologically. The initial imaging of choice to define the nodule is a CT scan that has been followed by an MRI for better description in a few cases.141517 The role of PET scans in differentiating LMM from other entities (eg, fibroma) is still unclear. In the patient our case, an increased uptake was noted that might help differentiating an LMM from other entities; however, it must be emphasized that the role of PET scanning in diagnosing LMMs is yet to be defined. Similarly, only a handful of patients have been biopsied with imaging techniques, probably because of the small size of the tumor and occasionally because of their location. Again, the role of biopsy with improved imaging modalities is also yet to be determined.

LMM has better overall outcome than DMM. However, in LMM, according to our review of the literature, neither the histologic subtype nor tumor size was found to correlate with survival (Table 1)Go. One of the important features of LMM is that many cases can apparently be cured with early surgical intervention. In contrast to other studies in our review, half of the patients in the study by Allen et al10 were alive, many after a significant period of follow-up. The authors of this study were unsure whether this was due to a slightly different case definition or to other factors such as better imaging modalities, improved staining procedures, earlier intervention, or advanced surgical techniques.

Those cases in the literature that were reported to recur tend to metastasize in the fashion of sarcomas, emphasizing their differences from DMM. While chemotherapy has a definitive role in DMM, very little if any information is available on the role of chemotherapy in patients with LMM and also in those patients where it reoccurs (Table 1)Go.

Pathologic Discussion
Mesotheliomas are classified into localized and diffuse types, of mesothelial and submesothelial origin, respectively. Localized mesotheliomas of submesothelial origin are now called solitary fibrous tumors. Until the 1980s, the term fibrous mesothelioma was often used for what is now called SFT. Some of these older articles may have been referring to SFT when they discussed LMM. SFT and malignant mesothelioma are now recognized to be completely different neoplasms with important clinical, radiologic, and pathologic differences, and the term fibrous mesothelioma is no longer used for SFT, as SFTs are considered to be of mesenchymal stem cell origin. Mesothelioma cell origin is rare and may be of epithelioid, sarcomatoid (spindle), or biphasic subtypes.4567891011121314151617

Immunohistochemisty is useful in differentiating mesothelioma from adenocarcinoma, which can present similarly.123242526272829 Although not pathognomonic, an immunohistochemical profile that is positive for calretinin, keratin, thrombomodulin, and vimentin, and is negative for CEA, SP-A, and CD15, the markers for adenocarcinoma, is highly suggestive of the mesothelial origin of the cells.12426 Some authors have suggested that the proliferation index of 67Ki should be part of the pathology report, as it was found to have an important prognostic value.30313233

The characteristic appearance of mesothelial cells on electron microscopy (ie, numerous long, slender, and smooth microvilli) point to the diagnosis of mesothelioma.1329 By definition, LMMs are immunohistochemically, and ultrastructurally identical to DMMs. Epithelium-type LMMs predominate, and very few tumors are purely sarcomatous. DMMs show macroscopic and/or microscopic evidence of widespread tumors on the serosal surface, whereas LMMs are well circumscribed. Reported cases34353637 of LMM that recur as DMM should be carefully reviewed to ensure that a DMM was not present at the time of the original diagnosis. In conclusion, we would suggest that, although LMMs share similar microscopic and immunohistochemical features with DMMs, LMM should probably be considered a separate entity, distinct by its occult clinical presentation, its sharp morphologic demarcation, and its higher curability with surgical resection.

Footnotes

The authors have reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.

Received for publication March 14, 2006. Accepted for publication September 8, 2006.

References

  1. Churg, A, Cagle, PT, Roggli, VL (2006) Tumors of the serosal membranes. Atlas of tumor pathology. 4th series, fascicle 10. Armed Forces Institute of Pathology. Washington, DC:
  2. Hammer, DP Pleural diseases. Dial, DH Hammer, SP eds. Pulmonary pathology 2nd ed. 1994,1463-1579 Springer. New York, NY:
  3. Suzuki, Y Diagnostic criteria for human diffuse malignant mesothelioma. Acta Pathol Jpn 1992;42,767-786[Medline]
  4. Sane, AC, Roggli, VL Curative resection of a well-differentiated papillary mesothelioma of the pericardium. Arch Pathol Lab Med 1995;119,266-267[ISI][Medline]
  5. Bierhoff, E, Pfeifer, U Malignant mesothelioma arising from a benign mediastinal mesothelial cyst. Gen Diagn Pathol 1996;142,59-62[Medline]
  6. Shimazaki, H, Shinsuke, A, Yasuhiro, I, et al Vacuolated cell mesothelioma of the pericardium resembling liposarcoma: a case report. Hum Pathol 2000;31,767-770[CrossRef][ISI][Medline]
  7. Val-Bernal, JF, Figols, J, Gomez-Romain, JJ Incidental (solitary) epithelial mesothelioma of the pericardium: case report and literature review. Cardiovasc Pathol 2002;11,181-185[CrossRef][ISI][Medline]
  8. Matsukuma, S, Aida, S, Hata, Y, et al Localized malignant peritoneal mesothelioma containing rhabdoid cells. Pathol Int 1996;46,389-391[ISI][Medline]
  9. Imura, J, Ichikawa, K, Takeda, J, et al Localized malignant mesothelioma of the epithelial type occurring as a primary hepatic neoplasm: a case report with review of the literature. APMIS 2002;110,789-794[CrossRef][ISI][Medline]
  10. Allen, TC, Cagle, PT, Churg, AM, et al Localized malignant mesothelioma. Am J Surg Pathol 2005;29,866-873[CrossRef][ISI][Medline]
  11. Obers, VJ, Leiman, G, Girdwood, RW, et al Primary malignant pleural tumors (mesotheliomas) presenting as localized masses: fine needle aspiration cytologic findings, clinical and radiologic features and review of the literature. Acta Cytol 1988;32,567-575[ISI][Medline]
  12. Crotty, BT, Myers, JL, Katzenstein, AA, et al Localized malignant mesothelioma. Am J Surg Pathol 1994;18,357-363[ISI][Medline]
  13. Ojeda, HF, Mech, K, Hicken, W Localized malignant mesothelioma: a case report. Am Surg 1998;64,881-885[ISI][Medline]
  14. Erkilic, S, Sari, I, Tuncozgur, B Localized pleural malignant mesothelioma. Pathol Int 2001;51,812-815[CrossRef][ISI][Medline]
  15. Okamura, H, Kamei, T, Mitsuno, A, et al Localized malignant mesothelioma of the pleura. Pathol Int 2001;51,654-660[CrossRef][ISI][Medline]
  16. Umezu, H, Kuwata, K, Ebe, Y, et al Microcystic variant of localized malignant mesothelioma accompanying an adenomatoid tumor-like lesion. Pathol Int 2002;52,416-422[CrossRef][ISI][Medline]
  17. Gomez-Roman, JJ, Mons-Lera, R, Olmedo, IS, et al Flow cytometric analysis of a localized malignant mesothelioma. Ann Thorac Surg 2002;73,1292-1294[Abstract/Free Full Text]
  18. Wagner E: Das tuberkelahnliche lymphadenom (Der cytogene oder reticulirte Tuberkel). Arch Heilk (Leipzig) 1870; 11:497
  19. Klemperer, P, Rabin, CB Primary neoplasms of the pleura: a report of five cases. Arch Pathol 1931;11,385-412
  20. Clagett, OT, Mcdonald, JR, Schmidt, HW Localized fibrous mesothelioma of the pleura. J Thorac Surg 1952;Sep; 24,213-230[Medline]
  21. Okike, N, Bernatz, PE, Woolner, LB Localized mesothelioma of the pleura; benign and malignant variants. J Thorac Cardiovasc Surg 1987;75,363-372
  22. Churg, A, Roggli, V, Galateau-Salle, F, et al Tumours of the pleura: mesothelial tumours. Travis, WD Brambilla, E Müller-Hermelink, HKet al eds. World Health Organization classification of tumours (vol 10): pathology and genetics of tumours of the lung, pleura, thymus and heart 2004 IARC Press. Lyon, France:
  23. Brown, RW, Clark, GM, Tandon, AK, et al Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 1993;24,347-354[CrossRef][ISI][Medline]
  24. Doglioni, C, Tos, AP, Laurino, L, et al Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20,1037-1046[CrossRef][ISI][Medline]
  25. Oates, J, Edwards, C HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology 2000;36,341-347[CrossRef][ISI][Medline]
  26. Ordonez, NG The immunohistochemical diagnosis of mesothelioma/differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 1989;13,276-291[ISI][Medline]
  27. Riera, JR, Astengo-Osuna, C, Longmate, JA, et al The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval. Am J Surg Pathol 1997;21,1409-1419[CrossRef][ISI][Medline]
  28. Wick, MR, Loy, T, Mills, SE, et al Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma. a histochemical, ultrastructural, and immunohistologic study of 103 cases. Hum Pathol 1990;21,759-766[CrossRef][ISI][Medline]
  29. Oury, TD, Hammar, SP, Roggli, VL Ultrastructural features of diffuse malignant mesotheliomas. Hum Pathol 1998;29,1382-1392[CrossRef][ISI][Medline]
  30. Churg, A, Colby, TV, Cagle, P, et al The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 2000;24,1183-1200[ISI][Medline]
  31. Comin, CE, Anichini, C, Boddi, V, et al MIB-1 proliferation index correlates with survival in pleural malignant mesothelioma. Histopathology 2000;36,26-31[CrossRef][ISI][Medline]
  32. Beer, TW, Buchanan, R, Matthews, AW, et al Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype. Hum Pathol 1998;29,246-251[CrossRef][ISI][Medline]
  33. Sawada, N, Toshiyuki, I, Naito, Z, et al Immunohistochemical localization of endothelial cell markers in solitary fibrous tumor. Pathol Int 2002;52,769-776[CrossRef][ISI][Medline]
  34. Gotfried, MH, Quan, SF, Sobonya, RE Diffuse epithelial pleural mesothelioma presenting as a solitary lung mass. Chest 1983;84,99-101
  35. Dalton, WT, Zolliker, AS, McCaughey, WTE, et al Localized primary tumors of the pleura: an analysis of 40 cases. Cancer 1979;44,1465-1475[CrossRef][ISI][Medline]
  36. England, DM, Hochholzer, L, McCarthy, MJ Localized benign and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases. Am J Surg Pathol 1989;13,640-658[ISI][Medline]
  37. Goldblum, J, Hart, WR Localized and diffuse mesotheliomas of the genital tract and peritoneum in women: a clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol 1995;19,1124-1137[ISI][Medline]




This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, A. M.
Right arrow Articles by Berman, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, A. M.
Right arrow Articles by Berman, A. R.
Related Content
Right arrow Chest Imaging and Pathology for Clinicians


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS